Press Release | NeoGenomics Laboratories

December 11, 2024

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

December 9, 2024

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

November 19, 2024

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

November 14, 2024

Felicia Williams Joins NeoGenomics Board of Directors

November 8, 2024

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

November 5, 2024

NeoGenomics Reports Third Quarter 2024 Results

October 22, 2024

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

October 15, 2024

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients